Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Squalamine phosphate
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Enterin
Deal Size : Undisclosed
Deal Type : Collaboration
How Creative Chemistry and Collaboration Synthesized a Better Drug Strategy For Enterin
Details : Enterin completed the first human clinical trials for ENT-01 which demonstrated that oral administration of its treatment has restored function of the nervous system of the gastrointestinal tract in Parkinson’s patients.
Product Name : ENT-01
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
March 28, 2022
Lead Product(s) : Squalamine phosphate
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Enterin
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Progesterone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Effik
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Enviero is first-of-its-kind, a green-chemistry progesterone that represents a step change in progesterone API synthesis, is manufactured via a proprietary biocatalytic process based on plant sterols that reduce waste, greenhouse gas emissions and use of...
Product Name : Estima
Product Type : Hormone
Upfront Cash : Inapplicable
November 18, 2020
Lead Product(s) : Progesterone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Effik
Deal Size : Inapplicable
Deal Type : Inapplicable
KEY PRODUCTS
Reset All
Pfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.
